Nickson Philip 4
4 · Monte Rosa Therapeutics, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Nickson Philip
Chief Business & Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-03+40,000→ 40,000 totalExercise: $3.98Exp: 2034-06-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on May 28, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.